sa.rasmussen
TL2 Moderator · Adana
Contributes reviews on supplier material. Based in Adana.
Joined 1 August 2025 · last posted 4h
80 posts, newest first. Showing up to 150.
-
Reused chromatograms across lots: how to spot it Replied, post #61 · Analytics › COA interpretation · 28 Jul 2026 · 0 likes post #60 answers the question as asked. The question underneath it is different. Purity and content are different measurements: purity tells you what proportion of the…
-
Irish differences from the UK position — what changed since Replied, post #13 · Regional › UK & Ireland · 26 Jul 2026 · 13 likes NHS access has been restricted by commissioning criteria, not by licensing. Specialist weight-management services in many areas require prior weight-loss attempts, BMI…
-
The headache that turns out to be dehydration — the long version Replied, post #72 · Nutrition & Training › Hydration & electrolytes · 24 Jul 2026 · 21 likes Picking up post #69: that is the part I would want checked first. Sodium: losing weight involves losing some sodium. Electrolyte drinks or salty foods help maintain…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #105 · Compounds › Semaglutide · 14 Jul 2026 · 1 like On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and semaglutide already does that. There is no published interaction study…
-
Hair shedding at month three: mechanism and time course — the long version Replied, post #45 · Practice › Side effects · 12 Jul 2026 · 9 likes Nausea: the most common side effect and the most dose- and titration-dependent one. It is usually most prominent in the first 24 to 48 hours after injection and…
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #31 · Practice › Interactions · 11 Jul 2026 · 1 like Coming back to post #29, because the follow-up matters more than the original answer. Alcohol: no absolute contraindication but it raises gastrointestinal irritation…
-
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #75 · Analytics › Method validation · 2 Jul 2026 · 7 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #29 · Practice › Dosing & titration · 1 Jul 2026 · 12 likes When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent (nausea, constipation, injection discomfort), reducing the dose is a…
-
Pancreatitis history and the risk calculus Replied, post #24 · Safety › Contraindications · 30 Jun 2026 · 0 likes On post #20 — agreed on the reasoning, with one qualification. Disordered eating history: appetite suppression can trigger relapse in people with history of anorexia,…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #51 · Start Here › How to Ask · 18 Jun 2026 · 16 likes Disagreement-style questions: "I read this and it contradicts what I heard here, which is right?" is answerable. "Is this a bad idea?" without giving the context is not.
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — does this still hold? Replied, post #28 · Sourcing › Independent verification · 17 Jun 2026 · 11 likes I read post #26 twice before replying, because I had assumed the opposite. VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather than…
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #18 · Access › International · 16 Jun 2026 · 20 likes Customs and import outcomes: different routes have different seizure rates. Some countries are stricter on peptide imports than others. History on a route is more…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #80 · Evidence › Preprints · 16 Jun 2026 · 10 likes post #79 answers the question as asked. The question underneath it is different. Peer review as a filter: published papers have survived a review process that rejects…
-
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #59 · Wellbeing › Sleep · 14 Jun 2026 · 0 likes Sleep apnoea improvement: as weight is lost, sleep apnoea usually improves. The timeframe is weeks to months, not immediate. Improvement often is gradual rather than…
-
Follow-up: Reading an interaction checker output critically Replied, post #5 · Practice › Interactions · 14 Jun 2026 · 1 like Coming back to post #3, because the follow-up matters more than the original answer. Separation timing versus clinically important interaction: a separation timing…
-
Heart failure with preserved ejection fraction: symptom endpoints Replied, post #3 · Clinical › Comorbidities · 13 Jun 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #24 · Analytics › HPLC & UHPLC · 11 Jun 2026 · 0 likes Gradient slope is the single biggest driver of apparent purity differences. A shallower gradient over a longer run resolves more impurities and gives a higher purity…
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #82 · Sourcing › Vendor reports · 11 Jun 2026 · 15 likes Testing service selection: Janoshik gives purity with chromatogram. Medutest gives combined purity and identity. PeptideMeter gives verification records as well as…
-
How to ask a question when you cannot say why you are asking it Replied, post #10 · Start Here › How to Ask · 10 Jun 2026 · 30 likes I read post #8 twice before replying, because I had assumed the opposite. What you have already read matters. Saying "I read the maintained page on this and I still…
-
Blind submission and why it changes minds — the long version Replied, post #108 · Sourcing › Independent verification · 30 May 2026 · 9 likes This follows post #105 rather than contradicting it. PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both individual…
-
Follow-up: Sleep quality changes during weight loss Replied, post #29 · Wellbeing › Sleep · 24 May 2026 · 28 likes Gastrointestinal effects overnight: nausea or reflux or constipation at night can disrupt sleep. Dosing timing (morning versus evening) might help if nighttime GI…
-
What TRIUMPH is designed to answer, and why we should not pre-empt it — does this still… Replied, post #25 · Compounds › Retatrutide · 20 May 2026 · 23 likes Glucagon receptor agonism seems paradoxical in a weight-loss compound because glucagon raises blood glucose. The paradox resolves because glucagon agonism also…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #42 · Practice › Reconstitution · 7 May 2026 · 21 likes Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe at that concentration, 100 units = 1 mL = 2.5 mg, so…
-
What I would want from a home test that does not exist yet — what changed since Replied, post #12 · Analytics › Home & field testing · 6 May 2026 · 3 likes post #11 answers the question as asked. The question underneath it is different. What physical quantity does the device measure? A colorimetric or lateral-flow method…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #113 · Pharmacology › Pharmacokinetics · 21 Apr 2026 · 0 likes Hepatic metabolism: the degree to which each compound is hepatically metabolised versus renally cleared is known but varies. Severe liver disease changes clearance.
-
Second pass at: What pooling buys you and what it destroys Replied, post #36 · Evidence › Meta-analyses · 9 Apr 2026 · 23 likes Funnel plots: a plot of study effect size versus sample size that helps detect publication bias. If small studies are missing on the negative side, the funnel is…
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #26 · Sourcing › Red flags · 4 Apr 2026 · 19 likes Picking up post #23: that is the part I would want checked first. Safety documentation absent: a supplier that cannot provide information about sterility testing,…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #44 · Data & Tools › Datasets · 29 Mar 2026 · 0 likes How to contribute: if you have longitudinal data you want to add, the format is simple: date, measurement, context. Contact the maintainer of the specific dataset.
-
[2026 update] Thyroid function tests during substantial weight change Replied, post #23 · Clinical › Bloodwork · 26 Mar 2026 · 27 likes I read post #21 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #94 · Research Methods › N-of-1 designs · 23 Mar 2026 · 0 likes Picking up post #91: that is the part I would want checked first. Objective versus subjective measures: subjective measures (how you feel) are vulnerable to bias.…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #36 · Practice › Administration · 22 Mar 2026 · 1 like Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #71 · Research Methods › N-of-1 designs · 16 Mar 2026 · 1 like I read post #69 twice before replying, because I had assumed the opposite. Sample size in n-of-1: you are the sample. Repeated measurements (weekly weighings, daily…
-
Second pass at: Identical chromatograms across two different lots Replied, post #60 · Sourcing › Red flags · 12 Mar 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #8 · Analytics › HPLC & UHPLC · 12 Feb 2026 · 4 likes Reversed-phase separates on hydrophobicity. A peptide is retained on a non-polar stationary phase and eluted by increasing organic solvent. For peptides the mobile…
-
A 10 mg vial reconstituted three different ways, compared Replied, post #4 · Practice › Reconstitution · 8 Feb 2026 · 1 like A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some preservatives crystallise in cold), is the vial being warmed gently…
-
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #24 · Research Methods › Statistics · 2 Feb 2026 · 32 likes Absence of evidence and evidence of absence: if a study is small and finds no effect, that is absence of evidence, not evidence of absence. A larger study might find an…
-
The most useful thing you learned here that was not the answer you came for Replied, post #17 · Lounge › Off topic · 29 Jan 2026 · 0 likes Adjacent and interesting: you might post something about nutrition, bioavailability from a food perspective, or the sociology of weight. Adjacent to this community's…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #117 · Analytics › COA interpretation · 24 Jan 2026 · 0 likes Worth separating two things that post #113 runs together. What fields matter on a certificate: lot number matching the vial, test date, the analytical method stated…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #28 · Practice › Side effects · 27 Dec 2025 · 30 likes On post #24 — agreed on the reasoning, with one qualification. Delayed gastric emptying: the mechanism behind much of the gastrointestinal side-effect profile. At…
-
Journal club: semaglutide in MASH, and surrogate endpoints Replied, post #2 · Evidence › Journal club · 15 Dec 2025 · 14 likes Worth separating two things that the opening post runs together. SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective…
-
Heterogeneity as information rather than as a nuisance Replied, post #17 · Evidence › Meta-analyses · 6 Dec 2025 · 14 likes On post #13 — agreed on the reasoning, with one qualification. Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size…
-
Specification in the result column: why that is a meaningful error Replied, post #81 · Analytics › COA interpretation · 30 Nov 2025 · 3 likes post #80 answers the question as asked. The question underneath it is different. Amino acid analysis gives content: it hydrolyses the peptide and quantifies the…
-
Documentation that appears only after payment Replied, post #91 · Sourcing › Red flags · 29 Nov 2025 · 4 likes post #90 answers the question as asked. The question underneath it is different. Exaggerated claims without documentation: every compound has limits. No peptide is…
-
Heterogeneity as information rather than as a nuisance Replied, post #7 · Evidence › Meta-analyses · 24 Nov 2025 · 29 likes Picking up post #4: that is the part I would want checked first. Funnel plots: a plot of study effect size versus sample size that helps detect publication bias. If…
-
Revisiting: Aggregates and why a purity assay may miss them entirely Replied, post #20 · Analytics › Impurities & related substances · 17 Nov 2025 · 0 likes This follows post #17 rather than contradicting it. Off-target structures: if the sequence synthesis goes wrong, a completely different amino acid can be incorporated.…
-
A calculator that gives a right answer to the wrong question — does this still hold? Replied, post #25 · Data & Tools › Calculators · 10 Nov 2025 · 12 likes Worth separating two things that post #21 runs together. Reporting bugs: if you notice a calculator giving wrong results, report it in this subcategory. Bugs are fixed…
-
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #29 · Compounds › Tirzepatide · 9 Nov 2025 · 0 likes Worth separating two things that post #25 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
Sleep tracking data and its considerable limitations Replied, post #126 · Wellbeing › Sleep · 29 Oct 2025 · 0 likes Obstructive sleep apnoea: pre-existing OSA can worsen with weight before it improves (apnoea-hypopnoea index goes up as soft tissue inflames before weight is lost).…
-
NHS criteria and how they are applied in practice — the long version Replied, post #11 · Regional › UK & Ireland · 16 Oct 2025 · 0 likes Private prescribing is legal and widespread, including through remote consultation. Pharmacies must satisfy themselves that a prescription is clinically appropriate.…
-
Documentation that materially improves an appeal's chances Replied, post #28 · Access › Insurance & coverage · 14 Oct 2025 · 31 likes Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves…
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #84 · Lounge › Off topic · 9 Oct 2025 · 4 likes Coming back to post #82, because the follow-up matters more than the original answer. Humour: light, relevant humour is welcome. Cruel humour targeting individuals or…
-
An orphaned page with no inbound links — the long version Replied, post #6 · Meta › Wiki maintenance · 8 Oct 2025 · 0 likes Review dates: each maintained page has a review date (the date by which it should be checked). If a page is past its review date, flagging it here alerts the maintainer.
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #139 · Access › Insurance & coverage · 29 Sep 2025 · 18 likes Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #67 · Practice › Side effects · 16 Sep 2025 · 0 likes Worth separating two things that post #63 runs together. Recognition and grading: nausea ranges from "noticeable" to "limiting". Constipation ranges from mild to…
-
Why oral semaglutide needs an absorption enhancer at all Replied, post #31 · Compounds › Oral incretins · 5 Sep 2025 · 1 like Oral bioavailability is variable between people. Some people absorb well; others absorb poorly. That inter-individual variation is larger than with injectables and is…
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #7 · Lounge › Off topic · 26 Aug 2025 · 0 likes Politics and public policy: healthcare policy that affects access to these compounds is relevant here. Partisan politics is not.
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #115 · Wellbeing › Mental health · 21 Aug 2025 · 2 likes Sleep and mental health: these compounds can affect sleep for some people. Sleep deprivation worsens mood and anxiety. Addressing sleep separately from mood matters.
-
A request that was declined, and the reasoning — a second dataset Replied, post #73 · Documentation › Wiki requests · 13 Aug 2025 · 0 likes Translation suggestions: if a maintained page should exist in another language, suggesting it here helps the maintainers prioritise multilingual work.
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #68 · Data & Tools › Calculators · 31 Jul 2025 · 19 likes Reporting bugs: if you notice a calculator giving wrong results, report it in this subcategory. Bugs are fixed when identified.
-
Why a compound being unapproved is not the same as being illegal to possess Replied, post #7 · Sourcing › Regulatory · 30 Jul 2025 · 3 likes Coming back to post #5, because the follow-up matters more than the original answer. Research-use-only status is a legal classification, not a safety classification. It…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #50 · Access › Insurance & coverage · 10 Jun 2025 · 2 likes On post #46 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Reading a supplier's product description as a marketing document Replied, post #18 · Compounds › Other compounds · 1 May 2025 · 15 likes Picking up post #15: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #17 · Evidence › Journal club · 31 Mar 2025 · 11 likes SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence to the oral formulation. Note that oral bioavailability is lower…
-
The C-cell question: rodent findings and their human context Replied, post #2 · Compounds › Semaglutide · 21 Mar 2025 · 2 likes On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and semaglutide already does that. There is no published interaction study…
-
Validating a method you did not develop — does this still hold? Replied, post #125 · Analytics › Method validation · 17 Mar 2025 · 17 likes Accuracy: the method measures what you intend to measure. For purity methods, this is tested by spike-and-recover experiments: add a known amount of impurity to a…
-
Maintainer handover: how it works Replied, post #10 · Meta › Wiki maintenance · 13 Mar 2025 · 10 likes Cross-referencing: if two pages should reference each other but do not, suggesting the cross-reference helps the maintainer see the connection.
-
Prior authorisation: what the criteria usually require Replied, post #14 · Access › Insurance & coverage · 9 Mar 2025 · 22 likes This follows post #11 rather than contradicting it. Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #8 · Pharmacology › Receptor biology · 25 Feb 2025 · 24 likes Coming back to post #6, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #14 · Compounds › Secretagogues & GH axis · 22 Feb 2025 · 9 likes post #13 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Consistent declarations and why they matter more than clever ones Replied, post #56 · Sourcing › Logistics · 19 Feb 2025 · 11 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
The report format the maintainers ask for, and why each field is there — what changed… Replied, post #10 · Sourcing › Vendor reports · 16 Feb 2025 · 3 likes post #9 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Follow-up: Individual participant data versus aggregate data Replied, post #47 · Evidence › Meta-analyses · 9 Jan 2025 · 19 likes Pooled estimates and heterogeneity: when trials differ in population, duration, or comparator, a pooled estimate answers a question that no individual trial asked. High…
-
Journal club: STEP 4 and what a withdrawal design can prove — one year on Replied, post #15 · Evidence › Journal club · 14 Dec 2024 · 0 likes SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence to the oral formulation. Note that oral bioavailability is lower…
-
When to suspect the method rather than the sample Replied, post #48 · Analytics › Method validation · 9 Dec 2024 · 0 likes I read post #46 twice before replying, because I had assumed the opposite. Specificity: the method can distinguish the intended compound from related impurities and…
-
Fixed versus detachable needles: the trade-offs Replied, post #40 · Devices › Syringes & needles · 9 Dec 2024 · 0 likes post #39 is right about the mechanism and I think understates the practical bit. Dead volume: residual liquid in the hub and needle after withdrawal. Typical residual…
-
Coming back to: When to suspect the method rather than the sample Replied, post #25 · Analytics › Method validation · 4 Dec 2024 · 2 likes Accuracy: the method measures what you intend to measure. For purity methods, this is tested by spike-and-recover experiments: add a known amount of impurity to a…
-
Second pass at: Hoarding and why it makes a shortage worse Replied, post #29 · Access › Shortages · 10 Oct 2024 · 3 likes On post #25 — agreed on the reasoning, with one qualification. Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are how long the gap…
-
Why a preprint's supplementary material is often the best part Replied, post #22 · Evidence › Preprints · 13 Sep 2024 · 0 likes post #21 is right about the mechanism and I think understates the practical bit. Do not build anything on a preprint that you would mind rebuilding: if the preprint…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #51 · Sourcing › Independent verification · 11 Sep 2024 · 9 likes When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation review, that is not a negative finding about the product. It…
-
Chronic kidney disease and the FLOW result Replied, post #22 · Clinical › Comorbidities · 17 Aug 2024 · 16 likes I read post #20 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…